In exploring the temporal relationship of the hallmark AD amyloid and tau pathologies in the context of impaired AHN, it is essential to examine changes occurring in the early stages of AD that may influence the neurogenic niches. The gene discussed is MAPT; the disease is Alzheimer disease.